MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein

Oncology Reports

Volumn 33, Issue 5, 2015, Pages 2309-2318

  Wu, Lei ^a,b   Hui, Hui ^b   Wang, Li Juan ^c   Wang, Hao ^a,b   Liu, Qiu Fang ^b   Han, Su Xia ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; MiR 326; Nin one binding protein; Prognosis; Proliferation

Indexed keywords

MICRORNA; MICRORNA 326; NIN ONE BINDING PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; MIRN326 MICRORNA, HUMAN; NOB1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NOB1 GENE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN TARGETING; SURVIVAL TIME; TUMOR GENE; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA; CELL MOTION; COLORECTAL TUMOR; GENETICS; HCT116 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 84927125967     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3840     Document Type: Article

References (45)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64:9-29, 2014.
2. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39:673-677, 2007.
3. Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W and Qin H: miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 61:1447-1453, 2012.
4. Almeida MI, Nicoloso MS, Zeng L, et al: Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142:886-896.e9, 2012.
5. Pichler M, Ress AL, Winter E, Stiegelbauer V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW, Kiesslich T, et al: MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer 110:1614-1621, 2014.
6. Sun HB, Chen X, Ji H, Wu T, Lu HW, Zhang Y, Li H and Li YM: miR-494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN. Int J Oncol 45:2486-2494, 2014.
7. Zhou J, Xu T, Yan Y, Qin R, Wang H, Zhang X, Huang Y, Wang Y, Lu Y, Fu D, et al: MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). PLoS One 8:e68469, 2013.
8. Du W, Liu X, Chen L, et al: Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness. Neuro Oncol 17:243-253, 2015.
9. Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E, Screpanti I, et al: Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 27:2616-2627, 2008.
10. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129, 2006.
11. + CML stem/progenitor cells. Int J Cancer 133:579-589, 2013.
12. Makarova KS, Aravind L, Galperin MY, Grishin NV, Tatusov RL, Wolf YI and Koonin EV: Comparative genomics of the Archaea (Euryarchaeota): Evolution of conserved protein families, the stable core, and the variable shell. Genome Res 9:608-628, 1999.
13. Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan Y, Tang W, Yu L and Zhao S: Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep 32:185-189, 2005.
14. Fatica A, Oeffinger M, Dlaki. M and Tollervey D: Nob1p is required for cleavage of the 3' end of 18S rRNA. Mol Cell Biol 23:1798-1807, 2003.
15. Huang WY, Chen DH, Ning L and Wang LW: siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells. Asian Pac J Cancer Prev 13:1823-1827, 2012.
16. Lin Y, Peng S, Yu H, Teng H and Cui M: RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol 29:311-317, 2012.
17. Li Y, Ma C, Qian M, Wen Z, Jing H and Qian D: Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo. Oncol Rep 31:1271-1276, 2014.
18. Lu Z, Guo Q, Shi A, Xie F and Lu Q: Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol Biol Rep 39:501-507, 2012.
19. Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E, Screpanti I, et al: Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J 27:2616-2627, 2008.
20. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129, 2006.
21. + CML stem/progenitor cells. Int J Cancer 133:579-589, 2013.
22. Makarova KS, Aravind L, Galperin MY, Grishin NV, Tatusov RL, Wolf YI and Koonin EV: Comparative genomics of the Archaea (Euryarchaeota): Evolution of conserved protein families, the stable core, and the variable shell. Genome Res 9:608-628, 1999.
23. Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan Y, Tang W, Yu L and Zhao S: Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep 32:185-189, 2005.
24. Fatica A, Oeffinger M, Dlakí M and Tollervey D: Nob1p is required for cleavage of the 3' end of 18S rRNA. Mol Cell Biol 23:1798-1807, 2003.
25. Huang WY, Chen DH, Ning L and Wang LW: siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells. Asian Pac J Cancer Prev 13:1823-1827, 2012.
26. Lin Y, Peng S, Yu H, Teng H and Cui M: RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol 29:311-317, 2012.
27. Li Y, Ma C, Qian M, Wen Z, Jing H and Qian D: Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo. Oncol Rep 31:1271-1276, 2014.
28. Lu Z, Guo Q, Shi A, Xie F and Lu Q: Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol Biol Rep 39:501-507, 2012.
29. He XW, Tao F, Luo SS and Yu XK: Effect of lentivirus-mediated NOB1 gene silencing by RNA interference on proliferation and apoptosis of human colon cancer cells. Zhonghua Wei Chang Wai Ke Za Zhi 15:1182-1186, 2012 (In Chinese).
30. Gao F and Wang W: MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein S1, forkhead box protein O1 (FOXO1) and FOXO3a. Mol Med Rep 11:1200-1206, 2015.
31. Xue G, Yan HL, Zhang Y, Hao LQ, Zhu XT, Mei Q and Sun SH: c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2. Oncogene: Apr 7, 2014 (Epub ahead of print). doi:10.1038/onc.2014.82.
32. Fernandez S, Risolino M, Mandia N, et al: miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene 0:2014.
33. Li T, Yang J, Lv X, Liu K, Gao C, Xing Y and Xi T: miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2. Biotechnol Lett 36:1743-1752, 2014.
34. Wu DP and He XW: Expression of NOB1 and its significance in colorectal cancer. Nan Fang Yi Ke Da Xue Xue Bao 32:420-422, 2012 (In Chinese).
35. Liu Y, Huang H, Yuan B, Zhuang LY, Luo TP and Zhang Q: Lentivirus-mediated knockdown of NOB1 suppresses the proliferation of colon cancer cells. Z Gastroenterol 52:429-435, 2014.
36. Meng W, Wang PS, Liu J, Xue S, Wang GM, Meng XY and Chen G: Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo. Oncol Rep 32:2411-2420, 2014.
37. Granneman S, Nandineni MR and Baserga SJ: The putative NTPase Fap7 mediates cytoplasmic 20S pre-rRNA processing through a direct interaction with Rps14. Mol Cell Biol 25:10352-10364, 2005.
38. Raychaudhuri S, Fontanes V, Barat B and Dasgupta A: Activation of ribosomal RNA transcription by hepatitis C virus involves upstream binding factor phosphorylation via induction of cyclin D1. Cancer Res 69:2057-2064, 2009.
39. Meraner J, Lechner M, Loidl A, Goralik-Schramel M, Voit R, Grummt I and Loidl P: Acetylation of UBF changes during the cell cycle and regulates the interaction of UBF with RNA polymerase I. Nucleic Acids Res 34:1798-1806, 2006.
40. Fasanaro P, Capogrossi MC and Martelli F: Regulation of the endothelial cell cycle by the ubiquitin-proteasome system. Cardiovasc Res 85:272-280, 2010.
41. Xu G, Bernaudo S, Fu G, Lee DY, Yang BB and Peng C: Cyclin G 2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7. Mol Biol Cell 19:4968-4979, 2008.
42. Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang G C, Yao XD and Zheng JH: Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Br J Cancer 111:1188-1200, 2014.
43. Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, Zhou L, Hu Y, Wang Q, Ni S, et al: MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein Cell 5:851-861, 2014.
44. Kjersem JB, Ikdahl T, Lingjaerde OC, Guren T, Tveit KM and Kure EH: Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatinbased treatment. Mol Oncol 8:59-67, 2014.
45. + channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 286:28656, 2011.